Brentuximub Vedoti Market

Brentuximab vedotin is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL (a type of T cell non-Hodgkin lymphoma).
Brentuximub Vedoti Market contains market size and forecasts of Brentuximub Vedoti in global, including the following market information:

• Global Brentuximub Vedoti Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Brentuximub Vedoti Market Sales, 2017-2022, 2023-2028, (K MT)
• Global top five Brentuximub Vedoti companies in 2021 (%)

The global Brentuximub Vedoti market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Podwer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Brentuximub Vedoti include Seattle Genetics and Takada etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Brentuximub Vedoti manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brentuximub Vedoti Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Brentuximub Vedoti Market Segment Percentages, by Type, 2021 (%)

• Podwer
• Liquid

Global Brentuximub Vedoti Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Brentuximub Vedoti Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Drugs Store
• Other

Global Brentuximub Vedoti Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Brentuximub Vedoti Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Brentuximub Vedoti revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Brentuximub Vedoti revenues share in global market, 2021 (%)
• Key companies Brentuximub Vedoti sales in global market, 2017-2022 (Estimated), (K MT)
• Key companies Brentuximub Vedoti sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Seattle Genetics
• Takada

To know more about market statistics, Download a FREE Sample copy